With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is ...
One-year outcomes in the ENCIRCLE trial’s main cohort (299 patients unsuitable for other treatment options) achieved low rates for death and low heart failure hospitalization for patients treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results